FDA

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.

NurOwn, a stem cell therapy, is at the center of a yearslong lobbying campaign by patients seeking access to experimental medicines. FDA regulators say the treatment hasn’t been shown to work.

The move came as a surprise: In May, an FDA advisory committee voted to recommend approval of the drug for children and adults.

These labels are found on most pre-packaged food items in the United States. They’re loaded with important information that can be difficult to decipher. Here’s how to read one of these labels.

If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers could be required to pull their oral medications containing phenylephrine from store shelves.

A panel of CDC advisers voted Tuesday to recommend updated Pfizer and Moderna coronavirus booster shots for everyone ages 6 months and up.

The U.S. Food and Drug Administration issued a warning for retailers selling illegal e-cigarettes disguised as toys, food items and school supplies. 

Narcan is an easy-to-use nasal spray that can reverse an opioid overdose. Here’s what you need to know about this life-saving drug.

The FDA advised people to not buy Dr. Berne’s MSM Drops 5% Solution and LightEyez MSM Eye Drops-Eye Repair drops.

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.

Under the new policy, all potential donor will answer the same eligibility question regardless of gender and sexual orientation.

Federal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.

The pills tested low for ascorbic acid, which could reduce their effectiveness and result in unwanted pregnancy, the FDA said.

The artificial sweetener is common in diet sodas and other low-calorie sweet foods.

If U.S. regulators approve, the drug would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease — after rival Leqembi. Both drugs pose a serious safety concern — brain swelling and bleeding.

The Food and Drug Administration said Thursday it cleared Perrigo’s once-a-day Opill to be sold without a prescription, making it the first such medication to be moved out from behind the pharmacy counter.

Sen. Charles Schumer, D-N.Y., called on the FDA to investigate PRIME, a beverage brand founded by YouTube stars Logan Paul and KSI, which is alleged to have an unsafe amount of caffeine.

An influencer-backed energy drink that has earned viral popularity among children is facing scrutiny from lawmakers and health experts over its potentially dangerous levels of caffeine.

Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.